Literature DB >> 30019760

Sex-specific density of ventricular SK currents: is this a general feature of SK channel function?

Dobromir Dobrev1.   

Abstract

Keywords:  SK channels; arrhythmia; sex

Year:  2018        PMID： 30019760      PMCID： PMC6138293          DOI： 10.1113/JP276663

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  5 in total

1.  Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles.

Authors:  Su-Kiat Chua; Po-Cheng Chang; Mitsunori Maruyama; Isik Turker; Tetsuji Shinohara; Mark J Shen; Zhenhui Chen; Changyu Shen; Michael Rubart-von der Lohe; John C Lopshire; Masahiro Ogawa; James N Weiss; Shien-Fong Lin; Tomohiko Ai; Peng-Sheng Chen
Journal:  Circ Res       Date:  2011-02-24       Impact factor: 17.367

2.  Sex-specific activation of SK current by isoproterenol facilitates action potential triangulation and arrhythmogenesis in rabbit ventricles.

Authors:  Mu Chen; Dechun Yin; Shuai Guo; Dong-Zhu Xu; Zhuo Wang; Zhenhui Chen; Michael Rubart-von der Lohe; Shien-Fong Lin; Thomas H Everett Iv; James N Weiss; Peng-Sheng Chen
Journal:  J Physiol       Date:  2018-07-19       Impact factor: 5.182

3.  Proarrhythmic effect of blocking the small conductance calcium activated potassium channel in isolated canine left atrium.

Authors:  Chia-Hsiang Hsueh; Po-Cheng Chang; Yu-Cheng Hsieh; Thomas Reher; Peng-Sheng Chen; Shien-Fong Lin
Journal:  Heart Rhythm       Date:  2013-01-30       Impact factor: 6.343

4.  Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

Authors:  Jordi Heijman; Dobromir Dobrev
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-10

Review 5.  Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy.

Authors:  Jonas G Diness; Bo H Bentzen; Ulrik S Sørensen; Morten Grunnet
Journal:  J Cardiovasc Pharmacol       Date:  2015-11       Impact factor: 3.105
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.